These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10412773)

  • 1. Mechanism of oral absorbent AST-120 in lipid abnormalities in experimental uremic rats.
    Yamakado M; Ise M
    Kidney Int Suppl; 1999 Jul; 71():S190-2. PubMed ID: 10412773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral sorbent AST-120 increases renal NO synthesis in uremic rats.
    Tumur Z; Niwa T
    J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis.
    Sato T; Liang K; Vaziri ND
    Kidney Int; 2003 Nov; 64(5):1780-6. PubMed ID: 14531811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].
    Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats.
    Aoyama I; Niwa T
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S7-S12. PubMed ID: 11158853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats.
    Niwa T; Yazawa T; Ise M; Sugano M; Kodama T; Uehara Y; Maeda K
    Nephron; 1991; 57(1):84-8. PubMed ID: 1904558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous nutrition on lipoprotein metabolism, body composition, weight gain and uremic state in experimental uremia in rats.
    Wennberg A; Norbeck HE; Sterner G; Lundholm K
    J Nutr; 1991 Sep; 121(9):1439-46. PubMed ID: 1908894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
    Aoyama I; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of oral sorbent in undialyzed uremia.
    Sanaka T; Sugino N; Teraoka S; Ota K
    Am J Kidney Dis; 1988 Aug; 12(2):97-103. PubMed ID: 3400639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uremic rats.
    Niwa T; Ise M; Miyazaki T; Meada K
    Nephron; 1993; 65(1):82-7. PubMed ID: 8413797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure.
    Okada K; Okawa E; Shibahara H; Maruyama T; Maruyama N; Matsumoto K; Takahashi S
    Kidney Blood Press Res; 2004; 27(4):218-25. PubMed ID: 15273424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic triiodothyronine supplementation does not improve the lipoprotein disorders of mildly uremic rats.
    Lacour B; Roullet JB; Ricordel Y; Drüeke T
    Nephron; 1987; 45(2):129-34. PubMed ID: 3550497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
    Niwa T; Ise M
    J Lab Clin Med; 1994 Jul; 124(1):96-104. PubMed ID: 8035108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral adsorbent ameliorates renal TGF-beta 1 expression in hypercholesterolemic rats.
    Aoyama I; Miyazaki T; Takayama F; Tsukushi S; Saga S; Shimokata K; Niwa T
    Kidney Int Suppl; 1999 Jul; 71():S193-7. PubMed ID: 10412774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys.
    Miyazaki T; Aoyama I; Ise M; Seo H; Niwa T
    Nephrol Dial Transplant; 2000 Nov; 15(11):1773-81. PubMed ID: 11071964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of weight loss and weight maintenance on the serum lipids, lipoprotein lipase and hepatic triglyceride lipase activities in obese rats.
    Kasim S; Jen KL
    Int J Obes; 1989; 13(3):279-88. PubMed ID: 2767881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postheparin lipolytic activity in acute and chronic renal failure.
    Gupta KL; Majumdar S; Sakhuja V
    Ren Fail; 1994; 16(5):609-15. PubMed ID: 7855316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oral sorbent, AST-120, increases Klotho expression and inhibits cell senescence in the kidney of uremic rats.
    Adijiang A; Niwa T
    Am J Nephrol; 2010; 31(2):160-4. PubMed ID: 19955715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.